Yahoo Web Search

Sign In

Search results

  1. reviewofmm.com › dirk-sauer-named-chairman-of-dopavisionsDirk Sauer Named Chairman of Dopavision’s Advisory Board

    Nov 17, 2022 · BERLIN, Germany — Dr. Dirk Sauer has been named the Chairman of Dopavision’s Advisory Board. Dr. Sauer brings a track record in the development of ophthalmic therapeutics and an industry network to advance MyopiaX, Dopavision’s therapeutic for childhood myopia control.

    • Kristen Dalli

  2. Images

    • Dirk Sauer Named Chairman of Dopavision's Advisory Board - Review of ...
    • Prof. Dr.-Ing. Dirk Sauer vom Campus Lingen ist „Professor des Jahres ...
    • Dirk Sauer 2 by T-R-F on DeviantArt
    • Dirk Sauer Oversees Novartis’ Promising & Productive Ophthalmic ...
    • Dirk Sauer

    View all

  3. graybug.gcs-web.com › news-releases › news-release-detailsGraybug Vision Appoints Dirk Sauer to Board of Directors

    “We are pleased to welcome Dirk Sauer to the Board as Jerry’s successor. His deep expertise in ophthalmic drug development will be invaluable as Graybug continues to advance its pipeline to address vision-threatening ocular diseases with high unmet needs."

  4. www.businesswire.com › news › homeDirk Sauer, Ph.D. Joins Iconic Therapeutics' Board of Directors

    Apr 20, 2021 · Dr. Sauer, based in Steinen, Germany, joined Novartis in 1989 as a postdoctoral fellow in the Neuroscience Preclinical Research Department. Over a period of more than 31 years, he...

  5. finance.yahoo.com › news › graybug-vision-appoints-dirk-sauerGraybug Vision Appoints Dirk Sauer to Board of Directors - Yahoo...

    Apr 13, 2022 · Graybug Vision, Inc. BALTIMORE, April 13, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for...

    • Graybug Vision, Inc.

  6. finance.yahoo.com › news › dopavision-appoints-dr-dirk-sauerDopavision Appoints Dr. Dirk Sauer as Chair of the Company's...

    Nov 16, 2022 · Dirk Sauer brings an exceptional track record in the development of ophthalmic therapeutics and an extensive industry network to advance MyopiaX ®, Dopavision's leading-edge digital...

  7. irp.cdn-website.com › fa16bb19 › filesFOR IMMEDIATE RELEASE Dirk Sauer, Ph.D. Joins Iconic Therapeutics...

    cancer, retinal disease and inflammation, today announced that Dirk Sauer, Ph.D., former Novartis Pharma AG’s Global Development Unit Head, Ophthalmology, has joined the company’s oard of Directors, bringing the current board membership to seven individuals.

  8. www.globenewswire.com › en › news-releaseDopavision Appoints Dr. Dirk Sauer as Chair of the -...

    Nov 16, 2022 · Dirk Sauer brings an exceptional track record in the development of ophthalmic therapeutics and an extensive industry network to advance MyopiaX ®, Dopavision's leading-edge digital therapeutic...